We are live on ! Find out more
SCM

Sio Capital Management Portfolio holdings

AUM $604M
1-Year Est. Return 96.57%
This Fund
S&P 500
This Quarter Est. Return
+2.01%
1 Year Est. Return
+96.57%
3 Year Est. Return
+564.25%
5 Year Est. Return
+486.18%
10 Year Est. Return
+2,856.71%
AUM
$193M
AUM Growth
-$17.7M
Cap. Flow
+$7.46M
Cap. Flow %
3.87%
Top 10 Hldgs %
52.19%
Holding
80
New
22
Increased
10
Reduced
12
Closed
26

Top Buys

Rank Stock Value
1
SIOX
Sio Gene Therapies Inc. Common Stock
SIOX
+$23.6M
2
DMK
DMK Pharmaceuticals Corporation Common Stock
DMK
+$9.19M
3
BIIB icon
Biogen
BIIB
+$4.6M
4
EGRX
Eagle Pharmaceuticals, Inc.
EGRX
+$3.86M
5
ZBH icon
Zimmer Biomet
ZBH
+$3.69M

Top Sells

Rank Stock Value
1
SNY icon
Sanofi
SNY
+$6.61M
2
TMO icon
Thermo Fisher Scientific
TMO
+$6.28M
3
HCA icon
HCA Healthcare
HCA
+$5.27M
4
PBYI icon
Puma Biotechnology
PBYI
+$4.91M
5
PHG icon
Philips
PHG
+$4.9M

Sector Composition

Rank Sector Weight
1 Healthcare 59.72%
2 Miscellaneous 35.2%
3 Financials 4.17%
4 Technology 0.91%
5 Industrials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SIOX
1
PUT
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$25M 12.99%
454,838
+451,125
+12,150% +$76.1M
SAGE
2
PUT
DELISTED
Sage Therapeutics
SAGE
$11.9M 6.15%
190,400
+130,400
+217% +$10.2M
QTNT
3
DELISTED
Quotient Limited Ordinary Shares
QTNT
$11.6M 6%
58,608
-520
-0.9% -$104K
DMK
4
DELISTED
DMK Pharmaceuticals Corporation Common Stock
DMK
$10.1M 5.25%
27,657
+25,907
+1,480% +$9.19M
INSM icon
5
PUT
Insmed
INSM
$25.9B
$8.33M 4.32%
266,800
+200
+0.1% +$3.81K
AET
6
DELISTED
Aetna Inc
AET
$8.03M 4.17%
50,523
-1,477
-3% -$231K
SIOX
7
DELISTED
Sio Gene Therapies Inc. Common Stock
SIOX
$7.7M 3.99%
+139,862
New +$23.6M
GSK icon
8
GSK
GSK
$102B
$6.97M 3.62%
137,355
+46,865
+52% +$2.38M
AGIO icon
9
PUT
Agios Pharmaceuticals
AGIO
$1.99B
$5.55M 2.88%
83,100
– –
SGEN
10
PUT
DELISTED
Seagen Inc. Common Stock
SGEN
$5.44M 2.82%
100,000
– –
BIIB icon
11
Biogen
BIIB
$32.3B
$4.87M 2.53%
+15,549
New +$4.6M
GMED icon
12
Globus Medical
GMED
$11.1B
$4.38M 2.27%
147,364
+33,964
+30% +$1.04M
MDT icon
13
Medtronic
MDT
$117B
$4.34M 2.25%
55,844
+25,844
+86% +$2.15M
KURA icon
14
Kura Oncology
KURA
$1.13B
$4.12M 2.14%
+275,731
New +$2.59M
GSK icon
15
CALL
GSK
GSK
$102B
$4.06M 2.11%
+80,000
New +$4.06M
RIGL icon
16
Rigel Pharmaceuticals
RIGL
$868M
$3.97M 2.06%
156,331
+21,759
+16% +$529K
AVNS
17
DELISTED
Avanos Medical
AVNS
$3.91M 2.03%
86,914
-13,685
-14% -$584K
EGRX
18
DELISTED
Eagle Pharmaceuticals, Inc.
EGRX
$3.81M 1.98%
+63,835
New +$3.86M
EBS icon
19
Emergent Biosolutions
EBS
$303M
$3.65M 1.89%
+90,268
New +$3.27M
ZBH icon
20
Zimmer Biomet
ZBH
$19.2B
$3.63M 1.89%
+31,964
New +$3.69M
AAAP
21
DELISTED
Advanced Accelerator Applications S.A.
AAAP
$3.56M 1.85%
52,582
-55,941
-52% -$2.72M
PBYI icon
22
Puma Biotechnology
PBYI
$468M
$3.26M 1.69%
27,221
-52,800
-66% -$4.91M
ZTS icon
23
PUT
Zoetis
ZTS
$32B
$3.19M 1.65%
+50,000
New +$3.13M
PHG icon
24
Philips
PHG
$26.1B
$2.79M 1.45%
89,359
-168,310
-65% -$4.9M
ICLR icon
25
Icon
ICLR
$13.1B
$2.69M 1.39%
+23,604
New +$2.51M
1
2 3 4

Similar funds

EFL
ERn Financial LLC Middleton, Wisconsin $604M AUM 19.83% 1-Year Est. Return
V
VeraBank Henderson, Texas $604M AUM 23.32% 1-Year Est. Return
MAM
Morse Asset Management Darien, Connecticut $604M AUM 72.61% 1-Year Est. Return
RCM
Requisite Capital Management Dallas, Texas $605M AUM 17.2% 1-Year Est. Return
AMG
Advisors Management Group La Crosse, Wisconsin $604M AUM 64.38% 1-Year Est. Return
VV
Verbena Value Westport, Connecticut $605M AUM
VCP
Varenne Capital Partners Paris, France $603M AUM 46.34% 1-Year Est. Return
EHI
Eagle Health Investments Greenwich, Connecticut $603M AUM 111.06% 1-Year Est. Return

Sio Capital Management's Q3 2017 Portfolio in Review

As of Q3 2017, Sio Capital Management held 80 positions worth $193M, down 8.4% from $210M the previous quarter. Its ten largest holdings account for 52% of the portfolio.

Sio Capital Management deployed $7.46M of net new capital in Q3 2017, opening 22 new positions and adding to 10 existing holdings. Its largest new stake was Sio Gene Therapies Inc. Common Stock: 139,862 shares worth $7.7M.

By sector, the portfolio is most concentrated in Healthcare at 60% of assets, up from 56% a quarter earlier, followed by Miscellaneous and Financials.

On the sell side, the largest reduction was Sanofi, an estimated $6.61M trimmed.

  • Sio Capital Management's largest Q3 2017 buy was Sio Gene Therapies Inc. Common Stock: 139,862 shares worth $7.7M.
  • Sio Capital Management added most to DMK Pharmaceuticals Corporation Common Stock in Q3 2017, an estimated $9.19M increase.
  • Sio Capital Management's biggest Q3 2017 reduction was Sanofi, cutting an estimated $6.61M.
  • Sio Capital Management fully exited Thermo Fisher Scientific in Q3 2017, selling an estimated $6.28M.
  • Sio Capital Management's ten largest holdings make up 52% of its $193M portfolio in Q3 2017.
  • Sio Capital Management opened 22 new positions and closed 26 in Q3 2017.
  • Sio Capital Management's portfolio value fell 8.4% quarter-over-quarter to $193M.

Based on Sio Capital Management's 13F filing for Q3 2017, filed 14 Nov 2017.